ProfileGDS5822 / ILMN_1242693
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 4% 10% 3% 2% 26% 11% 18% 8% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 17.64
GSM1276600PDAC Late Ablation Control 211.810
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 163
GSM1276603PDAC Late Ablation 23.32
GSM1276604PDAC Late Ablation 314.326
GSM1303940PDAC Late Ablation_anti-CTLA4 11011
GSM1303941PDAC Late Ablation_anti-CTLA4 210.218
GSM1303942PDAC Late Ablation_anti-CTLA4 35.58